Abstract:Background Programmed necrosis/necroptosis is an emerging form of cell death that plays important roles in mammalian development and the immune system. The pro-necrotic kinases in the receptor interacting protein (RIP) family are crucial mediators of programmed necrosis. Recent advances in necrosis research have been greatly aided by the identification of chemical inhibitors that block programmed necrosis. Necrostatin-1 (Nec-1) and its derivatives were previously shown to target the pro-necrotic kinase RIP1/RIPK1. The protective effect conferred by Nec-1 and its derivatives in many experimental model systems was often attributed to the inhibition of RIP1 function. Methodology/Principal Findings We compared the effect of Nec-1 and siRNA-mediated silencing of RIP1 in the murine fibrosarcoma cell line L929. Treatment of L929 cells with the pan-caspase inhibitor zVAD-fmk or exogenous TNF induces necrosis. Strikingly, we found that siRNA-mediated silencing of RIP1 inhibited zVAD-fmk induced necrosis, but not TNF-induced necrosis. TNF-induced cell death in RIP1 knocked down L929 cells was inhibited by Nec-1, but not the caspase inhibitor zVAD-fmk. We found that PKA-C§ expression, but not Jnk or Erk activation, was moderately inhibited by Nec-1. Moreover, we found that Nec-1 inhibits proximal T cell receptor signaling independent of RIP1, leading to inhibition of T cell proliferation. Conclusions/Significance Our results reveal that besides RIP1, Nec-1 also targets other factors crucial for necrosis induction in L929 cells. In addition, high doses of Nec-1 inhibit other signal transduction pathways such as that for T cell receptor activation. These results highlight the importance to independently validate results obtained using Nec-1 with other approaches such as siRNA-mediated gene silencing. We propose that some of the previous published results obtained using Nec-1 should be re-evaluated in light of our findings.

A Novel Zinc Finger Protein Interacts with Receptor-interacting Protein (RIP) and Inhibits Tumor Necrosis Factor (TNF)- and IL1-induced NF-κB Activation

Zinc Finger Protein 91 Mediates Necroptosis by Initiating RIPK1-RIPK3-MLKL Signal Transduction in Response to TNF Receptor 1 Ligation.

[Research Progress on Receptor Interacting Proteins in Inflammation].

Identification of a Nuclear Protein That Promotes NF-κB Activation

ZBP1 mediates interferon-induced necroptosis

Identification of A Zu5 and Death Domain-Containing Inhibitor of Nf-Kappa B

Znf216 is an A20-Like and I Kappa B Kinase Gamma-Interacting Inhibitor of Nf Kappa B Activation

ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1.

Casein kinase 1α interacts with RIP1 and regulates NF-κB activation

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis

A ZBP1 isoform blocks ZBP1-mediated cell death

Identification of RIP3, a RIP-like Kinase That Activates Apoptosis and NFκB

Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1

A shorter splicing isoform antagonizes ZBP1 to modulate cell death and inflammatory responses

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1

Trip6 is A Rip2-Associated Common Signaling Component of Multiple Nf-Kappa B Activation Pathways